3D Global Biotech Inc. (TPEX:6808)
Taiwan · Delayed Price · Currency is TWD 48.30
+0.30 (0.63%)
Dec 31, 2025, 2:59 PM CST
3D Global Biotech Market Cap
3D Global Biotech has a market cap or net worth of 3.76 billion as of December 31, 2025. Its market cap has increased by 20.86% in one year.
Market Cap
3.76B
Enterprise Value
3.08B
Revenue
324.87M
Ranking
n/a
PE Ratio
28.28
Stock Price
48.30
Market Cap Chart
Since December 25, 2020, 3D Global Biotech's market cap has increased from 2.74B to 3.76B, an increase of 37.40%. That is a compound annual growth rate of 6.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 3.76B | -26.72% |
| Dec 31, 2024 | 5.13B | 371.49% |
| Dec 29, 2023 | 1.09B | -27.35% |
| Dec 30, 2022 | 1.50B | -30.09% |
| Dec 30, 2021 | 2.14B | -18.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 240.39B |
| PharmaEssentia | 173.83B |
| Lotus Pharmaceutical | 74.42B |
| Heron Neutron Medical | 70.65B |
| Bora Pharmaceuticals Co., LTD. | 60.52B |
| Lin BioScience | 32.84B |
| Lumosa Therapeutics | 32.77B |
| Center Laboratories | 31.06B |